| 12/19/2005: |
Larta
Program Graduate Wins Governor's Innovation Award (v.7, n.29) |
| 12/05/2005: |
Larta
CEO Shukla to Keynote Commercialization Conference (v.7, n.28) |
| 11/14/2005: |
Project
T2 Conference Boosts Global Innovation (v.7, n.27) |
| 11/03/2005: |
Innovation:
A View from the North (v.7, n.26) |
| 10/24/2005: |
To
Market, To Market (v.7, n.25) |
| 10/10/2005: |
When
Worlds Collide: Project T2 Brings the Lab to the Market (v. 7, n.24) |
| 9/19/2005: |
The
Next Step in Search (v.7, n.23) |
| 7/25/2005: |
Making
the Connection (v.7, n.22) |
| 6/06/2005: |
Venture
Forum Attracts Leading Companies and Investors (v.7, n.21)
|
| 5/16/2005: |
Vecna
Charts Its Course (v.7, n.20) |
| 5/09/2005: |
National
Public Radio's Scott Horsley to Host Venture Forum Lunch (v.7, n.19) |
| 5/02/2005: |
Idun's
Steve Mento to Keynote Venture Forum 2005 (v.7, n.18) |
| 4/25/2005: |
California
Healthcare Institute's CEO Gollaher to Host Venture Forum Lunch
(v.7, n.17)
|
| 4/18/2005: |
Hewlett-Packard's
Johnson To Keynote Venture Forum 2005 (v.7, n.16) |
| 4/11/2005: |
Allergan's
Gibson To Keynote Venture Forum (v.7, n.15) |
| 4/04/2005: |
ProteoTech
Primes for Growth (v.7, n.14)
|
| 3/28/2005: |
Larta
Launches Israel Venture Program (v.7, n.13) |
| 3/21/2005: |
Venture
Forum Call for Applications (v.7, n.12)
|
| 3/14/2005: |
Raytheon's
Peter Pao To Deliver Venture Forum Keynote (v.7, n.11) |
| 3/07/2005: |
Larta
Vice President Turns Senior VP (v.7, n.10) |
| 2/28/2005: |
Larta
Issues Government Technology Funding Guide (v.7, n.9) |
| 2/21/2005: |
Larta
Helps Genzyme Find Opportunities (v.7, n.8) |
| 2/14/2005: |
Larta
Client Garners $4.9 Million in Financing (v.7, n.7) |
| 2/07/2005: |
Project
T2 Networking Pays Off (v.7, n.6) |
| 1/31/2005: |
Larta
President On Blue-Ribbon Nanotech Taskforce (v.7, n.5) |
| 1/24/2005: |
Larta
Announces Verizon Program Winners (v.7, n.4) |
| 1/17/2005: |
The
Key to Collaboration (v.7, n.3) |
| 1/10/2005: |
Venture
Forum Company Named Top 100 Innovator (v.7, n.2) |
| 1/03/2005: |
IP
Protection for Pharmacogenomics (v.7, n.1) |
| |
|
|
|
|
|
|
|
|
|